BD and Ypsomed’s Large‑Volume Biologic Autoinjector Collaboration Could Be A Game Changer For Becton Dickinson (BDX)

BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 ...
Drug Delivery Business

BD, Ypsomed to develop new syringe for biologics

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
WHNT

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™

TORONTO, April 8, 2025 /PRNewswire/ - AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global ...
Medscape

Biologic Overlap During Medication Switches Is Safe in IBD

Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...